Nykode Therapeutics AS (OSL:NYKD)
Norway
· Delayed Price · Currency is NOK 2.752
+0.092 (3.46%)
May 9, 2025, 4:25 PM CET
Nykode Therapeutics AS Revenue
In the year 2024, Nykode Therapeutics AS had annual revenue of $9.16M USD, down -31.26%. Nykode Therapeutics AS had revenue of $6.89M in the quarter ending December 31, 2024, with 227.46% growth.
Revenue
$9.16M
Revenue Growth
-31.26%
P/S Ratio
8.64
Revenue / Employee
$67.34K
Employees
136
Market Cap
898.66M NOK
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.16M | -4.17M | -31.26% |
| Dec 31, 2023 | 13.32M | 4.29M | 47.56% |
| Dec 31, 2022 | 9.03M | -26.74M | -74.76% |
| Dec 31, 2021 | 35.77M | -179.93M | -83.42% |
| Dec 31, 2020 | 215.70M | 214.28M | 15,175.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 603.92M |
| Nordhealth AS | 537.23M |
| Photocure ASA | 532.69M |
| Vistin Pharma ASA | 440.66M |
| Hofseth BioCare ASA | 265.54M |
| Omda AS | 426.27M |
| Gentian Diagnostics ASA | 158.07M |
| ArcticZymes Technologies ASA | 102.97M |